Drugs / Theravex Oral
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07430670 | Feb 2026 → Jul 2027 expected | gingival recession | Universidad Complutense de Madrid | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Theravex Oral | “Patients perform an immediate post-surgical rinse with 5 ml of Theravex Oral for 30 seconds.” NCT07430670 ↗ |
| Modality | Other / unclassified | “A novel bioactive saline solution containing calcium chloride and magnesium dichloride hexahydrate.” NCT07430670 ↗ |
| Route | Other | “patients rinse twice daily with Theravex Oral for a duration of 2 weeks.” NCT07430670 ↗ |